Caution Urged on SARS Vaccines

Abstract
WASHINGTON, D.C., AND ROTTERDAM-- A year of frenzied research has produced several candidate vaccines for severe acute respiratory syndrome. The first question is, how safe are they? And second, how will they be tested?

This publication has 0 references indexed in Scilit: